Literature DB >> 17311832

Correction: functional analysis of BRCA1 M1628V variant.

Marcelo A Carvalho, Alvaro N A Monteiro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17311832      PMCID： PMC2597988          DOI： 10.1136/jmg.2006.045344

Source DB:  PubMed          Journal:  J Med Genet        ISSN： 0022-2593            Impact factor:   6.318


× No keyword cloud information.
  5 in total

1.  Transcriptional activation by BRCA1.

Authors:  M S Chapman; I M Verma
Journal:  Nature       Date:  1996-08-22       Impact factor: 49.962

2.  Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families.

Authors:  J Vallon-Christersson; C Cayanan; K Haraldsson; N Loman; J T Bergthorsson; K Brøndum-Nielsen; A M Gerdes; P Møller; U Kristoffersson; H Olsson; A Borg; A N Monteiro
Journal:  Hum Mol Genet       Date:  2001-02-15       Impact factor: 6.150

3.  Classification of BRCA1 missense variants of unknown clinical significance.

Authors:  C M Phelan; V Dapic; B Tice; R Favis; E Kwan; F Barany; S Manoukian; P Radice; R B van der Luijt; B P M van Nesselrooij; G Chenevix-Trench; T Caldes; M de la Hoya; S Lindquist; S V Tavtigian; D Goldgar; A Borg; S A Narod; A N A Monteiro
Journal:  J Med Genet       Date:  2005-02       Impact factor: 6.318

4.  Evidence for a transcriptional activation function of BRCA1 C-terminal region.

Authors:  A N Monteiro; A August; H Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

5.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

Authors:  Y Miki; J Swensen; D Shattuck-Eidens; P A Futreal; K Harshman; S Tavtigian; Q Liu; C Cochran; L M Bennett; W Ding
Journal:  Science       Date:  1994-10-07       Impact factor: 47.728
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.